Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct binding domains (variable regions or complementarity-determining region surfaces) capable of binding two different antigens or two different epitopes of the same antigen.
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…
Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In
Read more